1. Home
  2. ASGN vs ANIP Comparison

ASGN vs ANIP Comparison

Compare ASGN & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASGN
  • ANIP
  • Stock Information
  • Founded
  • ASGN 1985
  • ANIP 2001
  • Country
  • ASGN United States
  • ANIP United States
  • Employees
  • ASGN N/A
  • ANIP N/A
  • Industry
  • ASGN Professional Services
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASGN Consumer Discretionary
  • ANIP Health Care
  • Exchange
  • ASGN Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • ASGN 2.1B
  • ANIP 2.0B
  • IPO Year
  • ASGN 1992
  • ANIP N/A
  • Fundamental
  • Price
  • ASGN $44.98
  • ANIP $92.62
  • Analyst Decision
  • ASGN Hold
  • ANIP Strong Buy
  • Analyst Count
  • ASGN 6
  • ANIP 7
  • Target Price
  • ASGN $59.67
  • ANIP $99.14
  • AVG Volume (30 Days)
  • ASGN 646.0K
  • ANIP 326.2K
  • Earning Date
  • ASGN 10-22-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • ASGN N/A
  • ANIP N/A
  • EPS Growth
  • ASGN N/A
  • ANIP N/A
  • EPS
  • ASGN 2.96
  • ANIP N/A
  • Revenue
  • ASGN $3,985,300,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • ASGN N/A
  • ANIP $40.23
  • Revenue Next Year
  • ASGN $0.62
  • ANIP $9.65
  • P/E Ratio
  • ASGN $15.22
  • ANIP N/A
  • Revenue Growth
  • ASGN N/A
  • ANIP 38.68
  • 52 Week Low
  • ASGN $42.77
  • ANIP $52.50
  • 52 Week High
  • ASGN $101.66
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • ASGN 43.91
  • ANIP 50.00
  • Support Level
  • ASGN $43.25
  • ANIP $89.47
  • Resistance Level
  • ASGN $45.49
  • ANIP $93.80
  • Average True Range (ATR)
  • ASGN 1.66
  • ANIP 3.23
  • MACD
  • ASGN -0.02
  • ANIP -0.03
  • Stochastic Oscillator
  • ASGN 37.43
  • ANIP 41.92

About ASGN ASGN Incorporated

ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: